Standard Contracts
UNDERWRITING AGREEMENT SOLITON, INC.Underwriting Agreement • August 30th, 2018 • Soliton, Inc. • Surgical & medical instruments & apparatus • California
Contract Type FiledAugust 30th, 2018 Company Industry JurisdictionSoliton, Inc., a Delaware corporation (the “Company”), proposes to issue and sell a minimum of 1,500,000 shares and a maximum of 3,000,000 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (“Common Stock”) to investors deemed acceptable by the Company (the “Investors”) in a public offering pursuant to Regulation A and to engage the several underwriters listed in Schedule A hereto (the “Underwriters”), for whom Boustead Securities, LLC is acting as a representative (the “Representative”) on a best efforts basis. The Underwriters have agreed to act, on a best efforts basis only, as the underwriters in connection with the offering and sale of the Shares (the “Offering”). The Company confirms its agreement with the Underwriters as follows:
NOTE PURCHASE AGREEMENTNote Purchase Agreement • August 30th, 2018 • Soliton, Inc. • Surgical & medical instruments & apparatus • Delaware
Contract Type FiledAugust 30th, 2018 Company Industry JurisdictionTHIS NOTE PURCHASE AGREEMENT (the “Agreement”) is made as of January 23, 2017, by and among Soliton, Inc., a Delaware corporation (the “Company”), and the lenders (each individually a “Lender,” and collectively the “Lenders”) named on the Schedule of Lenders attached hereto as Schedule 1 (the “Schedule of Lenders”). Capitalized terms not otherwise defined in this Agreement shall have the meanings ascribed to them in Section 1 below.
PATENT AND TECHNOLOGY LICENSE AGREEMENTPatent and Technology License Agreement • August 30th, 2018 • Soliton, Inc. • Surgical & medical instruments & apparatus • Texas
Contract Type FiledAugust 30th, 2018 Company Industry JurisdictionThis AGREEMENT (“AGREEMENT”) is made on this 5th day of April, 2012, by and between THE BOARD OF REGENTS (“BOARD”) of THE UNIVERSITY OF TEXAS SYSTEM (“SYSTEM”), an agency of the State of Texas, whose address is 201 West 7th Street, Austin, Texas 78701, on behalf of THE UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER (“UTMDACC”), a member institution of SYSTEM, and SOLITON, INC. a Delaware corporation having a principal place of business located at 1225 N. Loop West, Suite 725, Houston, Texas 77008 (“LICENSEE”).